Phibro Animal Health (PAHC) Misses Q3 EPS by 5c; Trims FY16 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Intel shares fall as competitor reports record results
- Marathon Petroleum to sell two refineries to CVR Energy for $4.2B
- AMD forecast eases AI spending fears as data-center sales surge
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
Phibro Animal Health Corporation Reports Third Quarter
May 9, 2016 4:17 PM EDTTEANECK, N.J., May 09, 2016 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ: PAHC) today announced its financial results for its third quarter ended March 31, 2016.
Highlights for the March 2016 quarter (compared to the March 2015 quarter, excluding $2 million of prior-year vaccine licensing milestone revenue and income) Net sales of $183 million, a decrease of 1%Adjusted EBITDA of $29.7 million, an increase of 16%Adjusted diluted EPS of $0.38, an increase of 6%Â COMMENTARY
Our third quarter was a continuation of many of the trends we have seen recently, with our... More



